Oxygen supply as a refining technique for injectable anesthesia in laboratory rats

Well-controlled anesthesia is critical to reducing potential surgical complications and ensuring safe and successful procedures. Respiratory depression, inducing hypoxia, and hypercapnia are adverse effects of injectable anesthesia in laboratory rats. This study aimed to determine the effect of oxygen supply in laboratory rats anesthetized with the combination of ketamine (K) and xylazine (X) plus acepromazine (A) or methadone (Me). The results showed that oxygenation allowed adequate levels of SO2 and paO2, avoiding hypoxemia. However, all anesthetized rats showed respiratory acidosis with low pH and high paCO2 levels, which was not reversed after oxygen administration. The acidosis could be related to hypoventilation due to respiratory depression induced by the XKMe association, as well as absorption atelectasis with the CO2 accumulation during anesthesia. Despite respiratory acidosis, oxygen administration was beneficial for anesthetized rats preventing hypoxemia. This makes it possible to prevent all the metabolic alterations that cause cell death by hypoxia, improving the well-being of anesthetized rats, as well as the quality of the results obtained.

Establishing an anesthetic protocol for refinement of intracerebral inoculation procedure

Mouse inoculation test (MIT) is a technique widely used for rabies diagnosis and must be liable to refinement due to animal welfare. The present study aims to compare five different anesthetic associations to stablish a protocol to improve the MIT procedure suitable for animal welfare and safe for a routine of viral isolation in newly weaned mice (3 weeks of age). 80 Swiss-Webster mice (Mus musculus) - 40 females and 40 males, 3-week-old, weight ranging from 11 to 14 grams ­ were used to conduct all procedures. Five anesthetic associations were tested: KX (Ketamine 100 mg/kg and Xylazine 10 mg/kg), KXA (Ketamine 80 mg/kg, Xylazine 5 mg/kg, and Acepromazine 1 mg/kg), KXT (Ketamine 80 mg/kg, Xylazine 5 mg/kg, and Tramadol 5 mg/kg), KXAT (Ketamine 100 mg/kg, Xylazine 10 mg/kg, Acepromazine 2 mg/kg and Tramadol 5 mg/kg) and ATI (Acepromazine 1 mg/kg + Tramadol 5 mg/kg + Isoflurane 5% - 0.5 L/min for induction and 2.5% - 0.5L/min for maintenance). Injectable anesthesia was administered intraperitoneally. We monitored the respiratory rate and body temperature. Response to anesthesia was evaluated according to the induction, surgical anesthesia, and recovery periods. The KXAT and ATI protocols induced surgical anesthesia, with the ATI protocol being the most appropriate and safe to perform the MIT procedure with 100% efficiency, absence of mortality, and rapid recovery of respiratory rate and temperature in the period after the procedure.

Protocolos para contenção química e eletroejaculação para coleta de sêmen de queixadas (Tayassu pecari) / Chemical restraining and electroejaculation protocols for semen collection in white-lipped peccary (Tayassu pecari)

Background: In order to reverse the White-lipped peccary decline, besides protecting its habitat and controlling hunting,it is necessary a captive breeding program. There are reports, however, on the low fertility of white-lipped peccary, makingit difficult its reproduction in captivity, making artificial insemination one of the main tools to prevent the loss of geneticdiversity of species kept in captivity. Information on safe methods of anesthesia and the collection of semen should beinvestigated. Therefore, we aimed to compare the effects of the anesthetic protocols acepromazine/ketamine and xylazine/ketamine, as well as electroejaculation protocols, for semen collection in white-lipped peccary (Tayassu pecari).Materials, Methods & Results: Twelve adult male white-lipped peccaries were submitted both to the xylazine/ketamineand acepromazine/ketamine anesthetic protocols. The anesthetic induction time and duration, the degree of muscle relaxation, the time for anesthetic recovery and the quality of the animals’ recovery were evaluated. Additionally, the qualityof the sedation was evaluated based on the animal’s behavior. We also evaluated the effect of drugs on erectile functionsas well as the efficiency of 3 electroejaculation protocols with increasing or fixed voltages (2 to 4 V; 5 to 12 V; 12 V). Theacepromazine/ketamine combination promotes shorter induction time, duration and recovery from anesthesia than thexylazine/ketamine association. There were no differences, however, between the tested anesthetic protocols in relation toheart rate, respiratory rate and temperature. Ejaculate was obtained from only 2 animals when using the xylazine/ketamineprotocol and adoption of stimuli between 5 and 12 V, with 10 stimuli at each voltage. In turn, ejaculate was obtained from4 animals submitted to the acepromazine/ketamine protocol, 3 of them with the adoption of stimuli between 5 and 12 V...

Protocolos para contenção química e eletroejaculação para coleta de sêmen de queixadas (Tayassu pecari) / Chemical restraining and electroejaculation protocols for semen collection in white-lipped peccary (Tayassu pecari)

Background: In order to reverse the White-lipped peccary decline, besides protecting its habitat and controlling hunting,it is necessary a captive breeding program. There are reports, however, on the low fertility of white-lipped peccary, makingit difficult its reproduction in captivity, making artificial insemination one of the main tools to prevent the loss of geneticdiversity of species kept in captivity. Information on safe methods of anesthesia and the collection of semen should beinvestigated. Therefore, we aimed to compare the effects of the anesthetic protocols acepromazine/ketamine and xylazine/ketamine, as well as electroejaculation protocols, for semen collection in white-lipped peccary (Tayassu pecari).Materials, Methods & Results: Twelve adult male white-lipped peccaries were submitted both to the xylazine/ketamineand acepromazine/ketamine anesthetic protocols. The anesthetic induction time and duration, the degree of muscle relaxation, the time for anesthetic recovery and the quality of the animals recovery were evaluated. Additionally, the qualityof the sedation was evaluated based on the animals behavior. We also evaluated the effect of drugs on erectile functionsas well as the efficiency of 3 electroejaculation protocols with increasing or fixed voltages (2 to 4 V; 5 to 12 V; 12 V). Theacepromazine/ketamine combination promotes shorter induction time, duration and recovery from anesthesia than thexylazine/ketamine association. There were no differences, however, between the tested anesthetic protocols in relation toheart rate, respiratory rate and temperature. Ejaculate was obtained from only 2 animals when using the xylazine/ketamineprotocol and adoption of stimuli between 5 and 12 V, with 10 stimuli at each voltage. In turn, ejaculate was obtained from4 animals submitted to the acepromazine/ketamine protocol, 3 of them with the adoption of stimuli between 5 and 12 V...(AU)

Bloqueio do plano transverso do abdômen guiado por ultrassom em felino submetido a mastectomia regional / Blocking of the abdomen transverse plan guided by ultrasound in feline submitted to regional mastectomy

Os bloqueios locorregionais vêm sendo cada vez mais utilizados na medicina veterinária. O bloqueio do plano transverso do abdômen (TAP Block) é uma técnica de anestesia locorregional, faz parte da estratégia de analgesia multimodal, capaz de promover anestesia e analgesia em regiões de pele, musculatura e peritônio parietal. O objetivo deste trabalho é relatar o bloqueio do plano transverso em um felino macho de dois anos de idade submetido a mastectomia regional. Foram feitos dois pontos de bloqueio do espaço TAP guiado por ultrassom, em cada lado do abdômen: um na parte caudal da região abdominal média, cranial a crista ilíaca, e o outro ponto, caudal a última costela, com 0,5mg/kg de bupivacaína a 0,25% em cada ponto, padronizando um volume injetado de 0,6mL. Foi utilizado acepromazina (0,05mg/kg), petidina (3mg/kg), cetamina (2mg/kg) e midazolam (0,3mg/kg) como medicação pré-anestésica, indução com propofol (3mg/kg) e manutenção por anestesia inalatória com isoflurano. Conclui-se que o TAP block foi eficaz para mastectomia regional abdominal, com alto índice de segurança e de fácil execução com treinamento adequado, mesmo com transdutores de baixa frequência.

Locoregional blocks have been increasingly used in veterinary medicine. Blocking the transverse plane of the abdomen (TAP Block) is a technique of locoregional anesthesia, it is part of the multimodal analgesia strategy, capable of promoting anesthesia and analgesia in regions of skin, musculature and parietal peritoneum. The aim of this study is to report the transverse plane block in a two-year-old male cat undergoing regional mastectomy. Two ultrasound-guided TAP space block points were made on each side of the abdomen: one in the caudal part of the middle abodminal region, cranial to the iliac crest, and the other point, caudal to the last rib, with 0.5mg/kg of 0.25% bupivacaine at each point, standardizing an injected volume of 0.6mL. Acepromazine (0.05mg/kg), pethidine (3mg/kg), ketamine (2mg/kg) and midazolam (0.3mg/kg) were used as pre-anesthetic medication, induction with propofol (3mg/kg) and maintenance by inhalation anesthesia with isoflurane. It is concluded that the TAP block was effective for regional abdominal mastectomy, with a high safety index and easy to perform with adequate training, even with less frequent transducers.

Intraocular pressure and pupil diameter in healthy cats anesthetized with isoflurane and pre-medicated with isolated acepromazine or in combination with tramadol / [Pressão intraocular e diâmetro pupilar em gatos saudáveis anestesiados com isoflurano e pré-medicados com acepromazina isolada ou em combinação com tramadol]

The objective of this study was to determine changes on intraocular pressure (IOP) and pupil diameter (PD) in healthy cats anesthetized with isoflurane, and premedicated with acepromazine alone or in combination with tramadol. Thirty cats were allocated in two groups (n=15/each) and were treated with acepromazine (AG) or acepromazine/tramadol (ATG). PD and IOP were assessed before and following 30 (PM1), and 40 minutes (PM2) of treatments. Anesthesia was induced with propofol, and IOP and DP were recorded (A10) at 10 minute intervals until the end of anesthesia (A40). IOP decreased in AG and ATG, when comparing baseline with PM1. IOP decreased only in AG, in comparisons between baseline and PM2. During anesthesia, IOP did not change within and between groups. Comparisons between baseline with those recorded at PM1 and 2 showed that PD increased in the ATG. During anesthesia, PD decreased significantly in AG and ATG. Both protocols maintained the IOP within the reference range to perform corneal or intraocular surgery in healthy cats but did not sustain pre-anesthetic pupil dilation observed in ATG.(AU)

O objetivo do presente artigo é determinar possíveis alterações na pressão intraocular (PIO) e no diâmetro pupilar (DP) em gatos saudáveis anestesiados com isoflurano e pré-medicados com acepromazina isolada ou em combinação com acepromazina/tramadol. Trinta gatos saudáveis foram distribuídos aleatoriamente em dois grupos (n=15/cada) e tratados com acepromazina (GA) ou acepromazina/tramadol (GAT). DP e PIO foram avaliadas antes (basal) e após 30 (PM1) e 40 minutos (PM2) dos tratamentos. A anestesia foi induzida com propofol, e a PIO e o DP foram registrados (A10) a cada 10 minutos até o final da anestesia com isoflurano (A40). Ao se compararem os valores obtidos no basal com PM1, a PIO diminuiu em GA e GAT; com PM2, a PIO reduziu apenas no GA. Durante a anestesia, a PIO não diferiu dentro e entre os grupos. Comparações entre os valores basais e os registrados em PM1 e em PM2 mostraram que a DP aumentou significativamente no GAT. Durante a anestesia, o DP diminuiu significativamente em GA e GAT. Ambos os protocolos mantêm a PIO dentro dos valores de referência para realizar cirurgias corneanas ou intraoculares em gatos saudáveis, mas não sustentam a dilatação pupilar pré-anestésica observada em GAT.(AU)

Evaluation of the effects of acepromazine and xylazine on viability in an equine dermal cell line / Avaliação dos efeitos de acepromazina e xilazina na viabilidadedelinhagem celular dérmica de equino

Xylazine and acepromazine are drugs used exclusively in veterinary medicine. Xylazine is used as a sedative, analgesic, and tranquilizer while acepromazine is used as a sedative, pre-anesthetic, and anesthetic adjuvant. In vitro drug toxicity experimentation is essential to predict possible damage associated with treatment. This study was carried out to evaluate and compare the in vitro effects of acepromazine and xylazine on cell viability. Equine Dermis cells lines were used to examine different drug concentrations (0.02 mg/mL, 0.01 mg/mL, 0.005 mg/mL and 0.0025 mg/mL). An MTT assay was carried out to reveal cell viability. Both tested drugs reduced the viability of ED cells at 0.02 and 0.01 mg/mL. At 0.005 mg/mL, only acepromazine presented an effect. These results corroborate previous studies with xylazine. On the other hand, this is the first report about acepromazine and cell viability. Previous studies suggest that the mechanisms involved in reducing cell viability are apoptosis for xylazine and the activation of the autophagic pathway for acepromazine. Both mechanisms have been seen in other drugs of the same classes. These findings reveal that both acepromazine and xylazine cause concentration-dependent cytotoxicity in vitro. Future experiments could further elucidate the mechanisms by which this effect happens and thus circumvent the risk of potential tissue damag(AU)

Xilazina e acepromazina sãofármacos usados exclusivamente em medicina veterinária. A xilazina é usada como sedativo, analgésico e tranquilizante, enquanto a acepromazina é usada como sedativo, pré-anestésico e adjuvante anestésico. A experimentação de toxicidade de fármacos in vitroé essencial para prever possíveis danos associados ao tratamento. Nesse sentido, este estudo foi realizado com o objetivo de avaliar e comparar in vitroos efeitos da acepromazina e da xilazina na viabilidade celular. Células da linhagem Equine Dermis (ED) foram usadas para examinar diferentes concentrações de fármacos (0,02 mg/mL, 0,01 mg/mL, 0,005 mg/mL e 0,0025 mg/mL). O ensaio de MTT foi realizado para revelar a viabilidade celular. Ambos os fármacos testados reduziram a viabilidade das células ED em 0,02 e 0,01 mg/mL. A 0,005 mg/mL, apenas acepromazina apresentou efeito. Esses resultados corroboram estudos anteriores com xilazina. Por outro lado, este é o primeiro estudo sobre acepromazina e viabilidade celular. Estudos anteriores sugerem que os mecanismos envolvidos na redução da viabilidade celular são a apoptose para a xilazina, e a ativação da via autofágica para a acepromazina, ambos mecanismos observados em medicamentos dasmesmasclasses. Esses achados revelam que tanto a acepromazina quanto a xilazina causamcitotoxicidade in vitrodependente da concentração. Expeimentosfuturos podem elucidar ainda mais os mecanismos pelos quais esse efeito acontece e, assim, contornar o risco de possíveis danos aos tecidos.(AU)

Evaluation of the effects of acepromazine and xylazine on viability in an equine dermal cell line / Avaliação dos efeitos de acepromazina e xilazina na viabilidadedelinhagem celular dérmica de equino

Xylazine and acepromazine are drugs used exclusively in veterinary medicine. Xylazine is used as a sedative, analgesic, and tranquilizer while acepromazine is used as a sedative, pre-anesthetic, and anesthetic adjuvant. In vitro drug toxicity experimentation is essential to predict possible damage associated with treatment. This study was carried out to evaluate and compare the in vitro effects of acepromazine and xylazine on cell viability. Equine Dermis cells lines were used to examine different drug concentrations (0.02 mg/mL, 0.01 mg/mL, 0.005 mg/mL and 0.0025 mg/mL). An MTT assay was carried out to reveal cell viability. Both tested drugs reduced the viability of ED cells at 0.02 and 0.01 mg/mL. At 0.005 mg/mL, only acepromazine presented an effect. These results corroborate previous studies with xylazine. On the other hand, this is the first report about acepromazine and cell viability. Previous studies suggest that the mechanisms involved in reducing cell viability are apoptosis for xylazine and the activation of the autophagic pathway for acepromazine. Both mechanisms have been seen in other drugs of the same classes. These findings reveal that both acepromazine and xylazine cause concentration-dependent cytotoxicity in vitro. Future experiments could further elucidate the mechanisms by which this effect happens and thus circumvent the risk of potential tissue damag

Xilazina e acepromazina sãofármacos usados exclusivamente em medicina veterinária. A xilazina é usada como sedativo, analgésico e tranquilizante, enquanto a acepromazina é usada como sedativo, pré-anestésico e adjuvante anestésico. A experimentação de toxicidade de fármacos in vitroé essencial para prever possíveis danos associados ao tratamento. Nesse sentido, este estudo foi realizado com o objetivo de avaliar e comparar in vitroos efeitos da acepromazina e da xilazina na viabilidade celular. Células da linhagem Equine Dermis (ED) foram usadas para examinar diferentes concentrações de fármacos (0,02 mg/mL, 0,01 mg/mL, 0,005 mg/mL e 0,0025 mg/mL). O ensaio de MTT foi realizado para revelar a viabilidade celular. Ambos os fármacos testados reduziram a viabilidade das células ED em 0,02 e 0,01 mg/mL. A 0,005 mg/mL, apenas acepromazina apresentou efeito. Esses resultados corroboram estudos anteriores com xilazina. Por outro lado, este é o primeiro estudo sobre acepromazina e viabilidade celular. Estudos anteriores sugerem que os mecanismos envolvidos na redução da viabilidade celular são a apoptose para a xilazina, e a ativação da via autofágica para a acepromazina, ambos mecanismos observados em medicamentos dasmesmasclasses. Esses achados revelam que tanto a acepromazina quanto a xilazina causamcitotoxicidade in vitrodependente da concentração. Expeimentosfuturos podem elucidar ainda mais os mecanismos pelos quais esse efeito acontece e, assim, contornar o risco de possíveis danos aos tecidos.

Dispersão da lidocaína administrada por via epidural em cães posicionados em decúbito lateral ou esternal / [Dispersion of lidocaine epidurally administered to dogs positioned on lateral or external decubitus]

O objetivo do estudo foi verificar clinicamente a dispersão da lidocaína no espaço epidural de cães posicionados em diferentes decúbitos. Foram utilizados 16 cães, com peso médio de 17,5 quilogramas. Esses foram tranquilizados com acepromazina, anestesiados com propofol e alocados em dois grupos, conforme o decúbito de posicionamento: decúbito esternal (GE) e decúbito lateral direito (GLD). Ambos os grupos receberam lidocaína a 2%, no volume de 0,25mL/kg, e permaneceram no mesmo decúbito por 20 minutos. Em seguida, avaliou-se o bloqueio dos membros pélvicos e a extensão do bloqueio, a partir da sétima vértebra lombar, por meio de pinçamento interdigital e do panículo paravertebral. Foi, então, realizada cirurgia de orquiectomia. Após tal procedimento, avaliou-se o tempo total de bloqueio dos membros pélvicos. Todos os cães apresentaram bloqueio bilateral, sem diferenças quanto à extensão cranial entre os grupos, sendo a mediana de 7,5 (1-14) vértebras para GE e de 4 (1-14) para GLD. O tempo de bloqueio dos membros direito e esquerdo foi de 123 ± 26 e 130 ± 20 minutos, para GE, e de 120 ± 21 e 121 ± 20 minutos, para GLD, sem diferenças entre os grupos ou entre os membros. Conclui-se que o decúbito não interfere na distribuição da lidocaína administrada por via epidural.(AU)

The aim of this study was to clinically verify the dispersion of lidocaine in the epidural space of dogs placed in different positions. Sixteen dogs with an average weight of 17.5 kilograms were used. These were tranquilized with acepromazine, anesthetized with propofol and allocated to two groups: sternal decubitus (GE) and right lateral decubitus (GLD). Both groups received 2% of lidocaine in the volume of 0.25mL/kg and remained in the same position for 20 minutes. The blocking of the pelvic limbs and the extension of it from the seventh lumbar vertebra were evaluated by means of interdigital and paravertebral panniculus clamping. Orchiectomy surgery was then performed. Afterwards, the total blocking time of the pelvic limbs was evaluated. All dogs presented bilateral blocking, with no differences in cranial extension between groups, with a median of 7.5 (1-14) vertebrae for GE and 4 (1-14) for GLD. The blocking time of the right and left limbs were 123 ± 26 and 130 ± 20 minutes for GE, and 120 ± 21 and 121 ± 20 minutes for GLD with no difference between groups or between limbs. It is concluded that the decubitus does not interfere with the epidural lidocaine distribution.(AU)

Tratamento de tétano em égua gestante / Tetanus treatmentin pregnant mare / Tratamiento contra el tétanos em yegua preñada

O tétano é uma doença infecciosa não contagiosa, desencadeada pela ação de neurotoxinas produzidas pela bactéria Clostridium tetani. Dentre as espécies mais suscetíveis e de maior ocorrência em estudos epidemiológicos, destacam-se os equinos. Neste estudo de caso, foi atendido no Hospital Veterinário do IFPB campus Sousa, uma fêmea equina, SRD, 8 anos de idade, no 6º mês de gestação. O animal apresentava taquipneia, taquicardia, espasticidade dos membros, protrusão da terceira pálpebra, hiperestesia, cauda em bandeira, rigidez da musculatura do abdome e discreta rigidez da musculatura cervical. Com a intervenção medicamentosa baseada no uso de soro antitetânico, antibioticoterapia com benzilpenicilina benzatina, acepromazina e fluidoterapia à base de solução de ringer com lactato, associado ao repouso em ambiente silencioso e termicamente agradável, obteve-se resultados satisfatórios nos primeiros dias do inicio do tratamento e recuperação total após o 15º dia. Além disso, ao 15°dia pós-internamento e antecedendo a alta do animal foi realizada a avaliação ultrassonográfica transretal, confirmando a viabilidade fetal.

Tetanus is a non-contagious infectious disease triggered by neurotoxins produced by the bacterium Clostridium tetani. Horses are among the most susceptible species and also are frequent targets in epidemiological studies. In this case study, a mare, crossbred, 8 years old, in the sixth month of gestation, was assisted at the Veterinary Hospital at IFPB Sousa campus. The animal was presenting some clinical signs, such as tachypnea, tachycardia, limb spasticity, protrusion of the third eyelid, hyperesthesia, elevated tail, stiffness of the abdomen muscles and slight stiffness of the cervical muscles. Medicines treatment was based on the use of tetanus antitoxin, benzathine penicillin antibiotic therapy, acepromazine and lactate ringer's solution therapy, combined with a calm and thermally pleasant environment. Satisfactory results were obtained from the first days of treatment and full recovery of the animal after the 15th day of hospitalization. In addition, on the 15thday after admission at the hospital and before discharge, a transrectal ultrasound evaluation was performed, confirming fetal viability.

El tétano es uma enfermedad infecciosa desencadenada por la acción de las neurotoxinas producidas por la bacteria Clostridium tetani. Entre las especies más susceptibles y más frecuentes en estudios epidemiológicos, destacan los caballos. En este estudio de caso, fue vista en el Hospital Veterinario Campus Sousa de IFPB, una yegua preñada, SRD, de 8 años de edad, en el sexto mes degestación. El animal presentaba taquipnea, taquicardia, espasticidad, posición del caballete, protrusión del tercer párpado, hiperestesia, colade bandera, rigidez de los músculos del abdomen y leve rigidez de los músculos cervicales. Con la intervención farmacológica basada en el uso del suero antitetánico, la terapia con antibióticos benzatínicos y bencilpenicilinas, la acepromacina y la fluidoterapia basada en la solución de Ringer lactato, asociada con un descanso tranquilo y placentero térmicamente, se obtuvieron resultados satisfactorios en los primeros días de inicio del tratamiento. y recuperación completa después del día 15. Además, el día 15 después del ingreso y antes del alta del animal, se realizó una evaluación ecográfica transrectal, confirmando la viabilidad fetal.

Tratamento de tétano em égua gestante / Tetanus treatmentin pregnant mare / Tratamiento contra el tétanos em yegua preñada

O tétano é uma doença infecciosa não contagiosa, desencadeada pela ação de neurotoxinas produzidas pela bactéria Clostridium tetani. Dentre as espécies mais suscetíveis e de maior ocorrência em estudos epidemiológicos, destacam-se os equinos. Neste estudo de caso, foi atendido no Hospital Veterinário do IFPB campus Sousa, uma fêmea equina, SRD, 8 anos de idade, no 6º mês de gestação. O animal apresentava taquipneia, taquicardia, espasticidade dos membros, protrusão da terceira pálpebra, hiperestesia, cauda em bandeira, rigidez da musculatura do abdome e discreta rigidez da musculatura cervical. Com a intervenção medicamentosa baseada no uso de soro antitetânico, antibioticoterapia com benzilpenicilina benzatina, acepromazina e fluidoterapia à base de solução de ringer com lactato, associado ao repouso em ambiente silencioso e termicamente agradável, obteve-se resultados satisfatórios nos primeiros dias do inicio do tratamento e recuperação total após o 15º dia. Além disso, ao 15°dia pós-internamento e antecedendo a alta do animal foi realizada a avaliação ultrassonográfica transretal, confirmando a viabilidade fetal.(AU)

Tetanus is a non-contagious infectious disease triggered by neurotoxins produced by the bacterium Clostridium tetani. Horses are among the most susceptible species and also are frequent targets in epidemiological studies. In this case study, a mare, crossbred, 8 years old, in the sixth month of gestation, was assisted at the Veterinary Hospital at IFPB Sousa campus. The animal was presenting some clinical signs, such as tachypnea, tachycardia, limb spasticity, protrusion of the third eyelid, hyperesthesia, elevated tail, stiffness of the abdomen muscles and slight stiffness of the cervical muscles. Medicines treatment was based on the use of tetanus antitoxin, benzathine penicillin antibiotic therapy, acepromazine and lactate ringer's solution therapy, combined with a calm and thermally pleasant environment. Satisfactory results were obtained from the first days of treatment and full recovery of the animal after the 15th day of hospitalization. In addition, on the 15thday after admission at the hospital and before discharge, a transrectal ultrasound evaluation was performed, confirming fetal viability.(AU)

El tétano es uma enfermedad infecciosa desencadenada por la acción de las neurotoxinas producidas por la bacteria Clostridium tetani. Entre las especies más susceptibles y más frecuentes en estudios epidemiológicos, destacan los caballos. En este estudio de caso, fue vista en el Hospital Veterinario Campus Sousa de IFPB, una yegua preñada, SRD, de 8 años de edad, en el sexto mes degestación. El animal presentaba taquipnea, taquicardia, espasticidad, posición del caballete, protrusión del tercer párpado, hiperestesia, colade bandera, rigidez de los músculos del abdomen y leve rigidez de los músculos cervicales. Con la intervención farmacológica basada en el uso del suero antitetánico, la terapia con antibióticos benzatínicos y bencilpenicilinas, la acepromacina y la fluidoterapia basada en la solución de Ringer lactato, asociada con un descanso tranquilo y placentero térmicamente, se obtuvieron resultados satisfactorios en los primeros días de inicio del tratamiento. y recuperación completa después del día 15. Además, el día 15 después del ingreso y antes del alta del animal, se realizó una evaluación ecográfica transrectal, confirmando la viabilidad fetal.(AU)

Anesthetic quality and cardiovascular and respiratory effects of continuous intravenous infusion of tiletamine-zolazepam in bitches / Qualidade anestésica e efeitos cardiovascular e respiratória da infusão intravenosa contínua de tiletamina-zolazepam em cadelas

The objective of this study was to evaluate the quality and recovery from anesthesia promoted by the tiletamine-zolazepam (TZ) combination administered intravenously (IV) continuously in bitches pre-medicated with acepromazine. Eight cross-bred, clinically healthy bitches weighing 13.7 ±1.9kg on average were used in this study. After a food fast of 12 h and a water fast of four hours, the animals were treated with acepromazine (0.1mg/kg, intramuscular) and, after 15 minutes, anesthesia was induced with a combination of tiletamine-zolazepam (2mg/kg, IV) immediately followed by continuous IV infusion thereof at a dose of 2mg/kg/h for 60 min. The following parameters were measured in all animals immediately before administration of acepromazine (M15), immediately before anesthetic induction (M0), and at 5, 10, 20, 30, 40, 50, and 60 min after initiation of continuous infusion (M5, M10, M20, M30, M40, M50, and M60): electrocardiography (ECG), heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), body temperature (BT), and arterial hemogasometry, with the last performed only at experimental times M15, M0, M30, and M60. A subcutaneous electrical stimulator was used to evaluate the degree of analgesia. Myorelaxation and quality of anesthetic recovery were also assessed, classifying these parameters as excellent, good, and poor. Anesthetic recovery time was recorded in minutes. HR increased significantly at time M10 in relation to that at M-15, and at times M5, M10, M40, and M50 in relation to that at M0. MAP decreased significantly at M20 and M30 compared with the baseline. BT decreased significantly at M50 compared with that at M0, but no hypothermia was observed. RR showed significant reduction at M5, M10, and M20 in relation to that at M-15, and at M5 and M10 in relation to that at M0, and bradypnoea was observed during the first 20 min after anesthetic induction...(AU)

Objetivou-se avaliar a qualidade e a recuperação da anestesia promovida pela associação tiletamina-zolazepam, administrada por via intravenosa (IV) contínua, em cadelas pré-medicadas com acepromazina. Foram utilizadas oito cadelas, sem raças definidas, clinicamente sadias, pesando em média 13,7±1,9kg. Após jejum alimentar de 12 horas e hídrico de quatro horas, os animais foram medicados com acepromazina (0,1mg/kg, via intramuscular) e, após 15 minutos, a anestesia foi induzida com a associação tiletamina-zolazepam (2mg/kg, IV) seguida imediatamente pela infusão IV contínua da mesma, na dose de 2mg/kg/h, durante 60 minutos. Os parâmetros que foram mensurados em todos os animais, imediatamente antes da administração da acepromazina (M-15), imediatamente antes da indução anestésica (M0) e, aos 5, 10, 20, 30, 40, 50 e 60 minutos após o início da infusão contínua (M5, M10, M20, M30, M40, M50 e M60) foram os seguintes: eletrocardiografia (ECG), frequência cardíaca (FC), pressão arterial média (PAM), frequência respiratória (f), temperatura corpórea (TC) e hemogasometria arterial, esta sendo realizada apenas nos momentos M-15, M0, M30 e M60. Para avaliação do grau de analgesia foi empregado um estimulador elétrico subcutâneo. Também se avaliou o miorrelaxamento e a qualidade da recuperação anestésica, classificando estes parâmetros em: excelente, bom e ruim. O tempo de recuperação anestésica foi registrado em minutos. A FC aumentou significativamente no momento M10 em relação ao M-15, e nos momentos M5, M10, M40 e M50 em relação ao M0. A PAM diminuiu significativamente em M20 e M30 em comparação ao valor basal. A TC diminuiu significativamente em M50 em comparação ao M0, mas não foi observada hipotermia. A f apresentou uma redução significativa nos momentos M5, M10 e M20 em relação ao M-15, e em M5 e M10 em relação ao M0, sendo observado bradipneia durante os primeiros 20 minutos após a indução anestésica...(AU)

Anesthetic quality and cardiovascular and respiratory effects of continuous intravenous infusion of tiletamine-zolazepam in bitches / Qualidade anestésica e efeitos cardiovascular e respiratória da infusão intravenosa contínua de tiletamina-zolazepam em cadelas

The objective of this study was to evaluate the quality and recovery from anesthesia promoted by the tiletamine-zolazepam (TZ) combination administered intravenously (IV) continuously in bitches pre-medicated with acepromazine. Eight cross-bred, clinically healthy bitches weighing 13.7 ±1.9kg on average were used in this study. After a food fast of 12 h and a water fast of four hours, the animals were treated with acepromazine (0.1mg/kg, intramuscular) and, after 15 minutes, anesthesia was induced with a combination of tiletamine-zolazepam (2mg/kg, IV) immediately followed by continuous IV infusion thereof at a dose of 2mg/kg/h for 60 min. The following parameters were measured in all animals immediately before administration of acepromazine (M15), immediately before anesthetic induction (M0), and at 5, 10, 20, 30, 40, 50, and 60 min after initiation of continuous infusion (M5, M10, M20, M30, M40, M50, and M60): electrocardiography (ECG), heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), body temperature (BT), and arterial hemogasometry, with the last performed only at experimental times M15, M0, M30, and M60. A subcutaneous electrical stimulator was used to evaluate the degree of analgesia. Myorelaxation and quality of anesthetic recovery were also assessed, classifying these parameters as excellent, good, and poor. Anesthetic recovery time was recorded in minutes. HR increased significantly at time M10 in relation to that at M-15, and at times M5, M10, M40, and M50 in relation to that at M0. MAP decreased significantly at M20 and M30 compared with the baseline. BT decreased significantly at M50 compared with that at M0, but no hypothermia was observed. RR showed significant reduction at M5, M10, and M20 in relation to that at M-15, and at M5 and M10 in relation to that at M0, and bradypnoea was observed during the first 20 min after anesthetic induction. Significant decreases in the PR interval at times M10, M40, and M50 were observed in relation to that at M15. Amplitude of the R wave showed significant decrease at M20 compared with that at M-15. In the other ECG parameters, no significant difference was observed between the times evaluated. Hemogasometric parameters and analgesia did not show significant alterations. Myorelaxation and quality of anesthetic recovery were considered excellent. Recovery time was 15.1±7.7 min for positioning of sternal decubitus and 45.5±23.1 minutes for return of ambulation. Continuous IV administration of TZ combination does not produce satisfactory analgesia and does not cause severe cardiorespiratory and hemogasometric effects in bitches pre-medicated with acepromazine.(AU)

Objetivou-se avaliar a qualidade e a recuperação da anestesia promovida pela associação tiletamina-zolazepam, administrada por via intravenosa (IV) contínua, em cadelas pré-medicadas com acepromazina. Foram utilizadas oito cadelas, sem raças definidas, clinicamente sadias, pesando em média 13,7±1,9kg. Após jejum alimentar de 12 horas e hídrico de quatro horas, os animais foram medicados com acepromazina (0,1mg/kg, via intramuscular) e, após 15 minutos, a anestesia foi induzida com a associação tiletamina-zolazepam (2mg/kg, IV) seguida imediatamente pela infusão IV contínua da mesma, na dose de 2mg/kg/h, durante 60 minutos. Os parâmetros que foram mensurados em todos os animais, imediatamente antes da administração da acepromazina (M-15), imediatamente antes da indução anestésica (M0) e, aos 5, 10, 20, 30, 40, 50 e 60 minutos após o início da infusão contínua (M5, M10, M20, M30, M40, M50 e M60) foram os seguintes: eletrocardiografia (ECG), frequência cardíaca (FC), pressão arterial média (PAM), frequência respiratória (f), temperatura corpórea (TC) e hemogasometria arterial, esta sendo realizada apenas nos momentos M-15, M0, M30 e M60. Para avaliação do grau de analgesia foi empregado um estimulador elétrico subcutâneo. Também se avaliou o miorrelaxamento e a qualidade da recuperação anestésica, classificando estes parâmetros em: excelente, bom e ruim. O tempo de recuperação anestésica foi registrado em minutos. A FC aumentou significativamente no momento M10 em relação ao M-15, e nos momentos M5, M10, M40 e M50 em relação ao M0. A PAM diminuiu significativamente em M20 e M30 em comparação ao valor basal. A TC diminuiu significativamente em M50 em comparação ao M0, mas não foi observada hipotermia. A f apresentou uma redução significativa nos momentos M5, M10 e M20 em relação ao M-15, e em M5 e M10 em relação ao M0, sendo observado bradipneia durante os primeiros 20 minutos após a indução anestésica. Foram observadas diminuições significativas do intervalo PR nos momentos M10, M40 e M50, em relação ao M-15. A amplitude da onda R apresentou diminuição significativa em M20 em comparação ao M-15. Nos demais parâmetros da ECG não houve diferença significativa entre os momentos avaliados. Os parâmetros hemogasométricos e a analgesia não apresentaram alterações significativas. O miorrelaxamento e a qualidade da recuperação anestésica foram considerados excelentes. O período de recuperação foi de 15,1±7,7 minutos para posicionamento do decúbito esternal e 45,5±23,1 minutos para retorno da deambulação. A administração intravenosa contínua de tiletamina-zolazepam não produz analgesia satisfatória e não causa efeitos cardiorrespiratórios e hemogasométricos severos, em cadelas pré-tratadas com acepromazina.(AU)

Hypotension aggravated by dopamine in a dog under isoflurane anesthesia

Background: Hypotension (MAP < 60 mmHg) is the most common complication in anesthetic practice and has been identified in 38% of canine patients undergoing general anesthesia for variety of procedures. Normalization of arterial pressure can usually be achieved by decreases in inhalant anesthetic concentrations, fluid administration, and use of inotropes/ vasopressors in healthy animals (ASA I) or animals with mild systemic disease (ASA anesthetic risk II). The present report shows an ASA II dog with severe hypotensive crisis [mean arterial pressure (MAP) < 50 mmHg] during general anesthesia, in which the procedure was aborted because hypotension was aggravated by dopamine.Case: A 7-year-old male Bull Terrier was anesthetized for magnetic resonance imaging (MRI) of a tumor in the face. After intramuscular acepromazine (0.01 mg/kg) and meperidine (3 mg/kg), anesthesia was induced with intravenous (IV) ketamine (1 mg/kg) and propofol (2.3 mg/kg) and maintained with isoflurane in oxygen. Ten min after induction of anesthesia MAP was 45 mmHg, while end-tidal isoflurane (ETISO) concentration was 0.5%. End-tidal isoflurane was decreased to 0.3% and an IV bolus of Lactated Ringer’s was initiated (15 mL/kg over 10 min), followed by two ephedrine boluses (0.1 mg/kg, IV) administered 5 min apart. MAP remained low (< 50 mmHg) and dopamine constant rate infusion (CRI) was initiated (7.5 μg/kg/min). Ten minutes after dopamine CRI was commenced, MAP was further decreased to 25-22 mmHg. Dopamine CRI was increased to 10 μg/kg/min, but MAP remained < 25 mmHg. Infusion drugs and isoflurane anesthesia were stopped. After the animal was extubated MAP returned 60-70 mmHg.Discussion: Among the drugs used, isoflurane is known for decreasing blood pressure in a dose-related manner because of its vasodilating properties.[...]

Hypotension aggravated by dopamine in a dog under isoflurane anesthesia

Background: Hypotension (MAP < 60 mmHg) is the most common complication in anesthetic practice and has been identified in 38% of canine patients undergoing general anesthesia for variety of procedures. Normalization of arterial pressure can usually be achieved by decreases in inhalant anesthetic concentrations, fluid administration, and use of inotropes/ vasopressors in healthy animals (ASA I) or animals with mild systemic disease (ASA anesthetic risk II). The present report shows an ASA II dog with severe hypotensive crisis [mean arterial pressure (MAP) < 50 mmHg] during general anesthesia, in which the procedure was aborted because hypotension was aggravated by dopamine.Case: A 7-year-old male Bull Terrier was anesthetized for magnetic resonance imaging (MRI) of a tumor in the face. After intramuscular acepromazine (0.01 mg/kg) and meperidine (3 mg/kg), anesthesia was induced with intravenous (IV) ketamine (1 mg/kg) and propofol (2.3 mg/kg) and maintained with isoflurane in oxygen. Ten min after induction of anesthesia MAP was 45 mmHg, while end-tidal isoflurane (ETISO) concentration was 0.5%. End-tidal isoflurane was decreased to 0.3% and an IV bolus of Lactated Ringers was initiated (15 mL/kg over 10 min), followed by two ephedrine boluses (0.1 mg/kg, IV) administered 5 min apart. MAP remained low (< 50 mmHg) and dopamine constant rate infusion (CRI) was initiated (7.5 μg/kg/min). Ten minutes after dopamine CRI was commenced, MAP was further decreased to 25-22 mmHg. Dopamine CRI was increased to 10 μg/kg/min, but MAP remained < 25 mmHg. Infusion drugs and isoflurane anesthesia were stopped. After the animal was extubated MAP returned 60-70 mmHg.Discussion: Among the drugs used, isoflurane is known for decreasing blood pressure in a dose-related manner because of its vasodilating properties.[...](AU)

Effects of tramadol and acepromazine on intraocular pressure and pupil diameter in young healthy cats / Efeitos do tramadol e da acepromazina sobre a pressão intraocular e o diâmetro pupilar em gatos saudáveis jovens

This study aimed to investigate the effects of the systemic administration of acepromazine, tramadol and the association of both on intraocular pressure (IOP) and pupil diameter (PD) in young healthy cats. Cats were randomly allocated into three groups (n=10/each) and intramuscular acepromazine (AG), tramadol (TG) or acepromazine combined with tramadol (ATG) were injected. PD (electronic caliper) and IOP (applanation tonometry) were assessed before (baseline) and following 15, 30, 60, and 120 minutes of treatments. It was verified that in AG, PD decreased significantly from time point 30 to 120 (P=0.002), but such reduction did not differ significantly from baseline (P=0.89). In TG, PD increased significantly from the first 15 minutes, until the last time point of evaluation (P 0.001). In ATG, PD increased significantly from time point 30 to 120 when compared to baseline (P 0.001); but significant differences from time point 30 to 120 were not seen (P=0.71). Comparisons among groups showed that PD values of TG and ATG were significantly higher than that of AG (P 0.05). IOP values, on the other hand, did not change significantly among time points and groups (P>0.05). It can be concluded that tramadol alone or in association with acepromazine produced significant mydriasis for up to 120 minutes, without changing IOP values in normal cats. Results of this study suggested that tramadol alone or in association with acepromazine caused significant mydriasis and did not change IOP values in normal cats. Therefore, it may be considered a satisfactory pre-anesthetic combination for ophthalmic surgery in cats. However, further studies are warranted on the use of such protocols in cats with ophthalmic diseases undergoing ocular or intraocular surgery.(AU)

Objetivou-se estudar os efeitos da administração sistêmica da acepromazina, do tramadol e da associação de ambos sobre a pressão intraocular (PIO) e o diâmetro pupilar (DP) em gatos saudáveis jovens. Os gatos foram aleatoriamente distribuídos em três grupos (n=10/cada) e tratados pela via intramuscular com acepromazina (GA), tramadol (GT) ou acepromazina combinada ao tramadol (GAT). O DP (paquimetria eletrônica) e a PIO (tonometria de aplanação) foram mensurados antes (basal) e após 15, 30, 60, e 120 minutos após a administração dos tratamentos. Constatou-se que no GA, o DP reduziu significativamente a partir do 30 até o 120 minuto de avaliação (P=0.02), mas sem diferir significativamente em relação ao basal (P=0,89). No GT, o DP se elevou significativamente desde 15 minuto, até o último período de avaliação (P0.001). No GAT, o DP se elevou de forma significativa do 30 ao 120 minuto em comparação ao basal (P 0,001), mas esse parâmetro não alterou significativamente do 30º ao 120º minuto (P=0.71). Comparações entre os grupos mostraram que o DP do GT e do GAT apresentaram valores significativamente mais elevados que aqueles do GA (P 0,05). A PIO, por sua vez, não se alterou de forma significativa nos períodos e entre os grupos avaliados (P>0,05). Conclui-se que o tramadol, administrado de forma isolada ou em associação à acepromazina, produz midríase de até 120 minutos, sem alterar os valores da PIO em gatos saudáveis. Dessa forma, esse protocolo pré-anestésico pode ser considerado uma alternativa para cirurgia oftálmica em gatos. Todavia, os resultados desse protocolo em gatos com doença oftálmica, que necessitem de cirurgia, devem ser avaliados em estudos futuros.(AU)

Effects of tramadol and acepromazine on intraocular pressure and pupil diameter in young healthy cats / Efeitos do tramadol e da acepromazina sobre a pressão intraocular e o diâmetro pupilar em gatos saudáveis jovens

This study aimed to investigate the effects of the systemic administration of acepromazine, tramadol and the association of both on intraocular pressure (IOP) and pupil diameter (PD) in young healthy cats. Cats were randomly allocated into three groups (n=10/each) and intramuscular acepromazine (AG), tramadol (TG) or acepromazine combined with tramadol (ATG) were injected. PD (electronic caliper) and IOP (applanation tonometry) were assessed before (baseline) and following 15, 30, 60, and 120 minutes of treatments. It was verified that in AG, PD decreased significantly from time point 30 to 120 (P=0.002), but such reduction did not differ significantly from baseline (P=0.89). In TG, PD increased significantly from the first 15 minutes, until the last time point of evaluation (P 0.001). In ATG, PD increased significantly from time point 30 to 120 when compared to baseline (P 0.001); but significant differences from time point 30 to 120 were not seen (P=0.71). Comparisons among groups showed that PD values of TG and ATG were significantly higher than that of AG (P 0.05). IOP values, on the other hand, did not change significantly among time points and groups (P>0.05). It can be concluded that tramadol alone or in association with acepromazine produced significant mydriasis for up to 120 minutes, without changing IOP values in normal cats. Results of this study suggested that tramadol alone or in association with acepromazine caused significant mydriasis and did not change IOP values in normal cats. Therefore, it may be considered a satisfactory pre-anesthetic combination for ophthalmic surgery in cats. However, further studies are warranted on the use of such protocols in cats with ophthalmic diseases undergoing ocular or intraocular surgery.

Objetivou-se estudar os efeitos da administração sistêmica da acepromazina, do tramadol e da associação de ambos sobre a pressão intraocular (PIO) e o diâmetro pupilar (DP) em gatos saudáveis jovens. Os gatos foram aleatoriamente distribuídos em três grupos (n=10/cada) e tratados pela via intramuscular com acepromazina (GA), tramadol (GT) ou acepromazina combinada ao tramadol (GAT). O DP (paquimetria eletrônica) e a PIO (tonometria de aplanação) foram mensurados antes (basal) e após 15, 30, 60, e 120 minutos após a administração dos tratamentos. Constatou-se que no GA, o DP reduziu significativamente a partir do 30 até o 120 minuto de avaliação (P=0.02), mas sem diferir significativamente em relação ao basal (P=0,89). No GT, o DP se elevou significativamente desde 15 minuto, até o último período de avaliação (P0.001). No GAT, o DP se elevou de forma significativa do 30 ao 120 minuto em comparação ao basal (P 0,001), mas esse parâmetro não alterou significativamente do 30º ao 120º minuto (P=0.71). Comparações entre os grupos mostraram que o DP do GT e do GAT apresentaram valores significativamente mais elevados que aqueles do GA (P 0,05). A PIO, por sua vez, não se alterou de forma significativa nos períodos e entre os grupos avaliados (P>0,05). Conclui-se que o tramadol, administrado de forma isolada ou em associação à acepromazina, produz midríase de até 120 minutos, sem alterar os valores da PIO em gatos saudáveis. Dessa forma, esse protocolo pré-anestésico pode ser considerado uma alternativa para cirurgia oftálmica em gatos. Todavia, os resultados desse protocolo em gatos com doença oftálmica, que necessitem de cirurgia, devem ser avaliados em estudos futuros.

Echocardiographic parameters in dogs treated with acepromazine and fentanyl / Parâmetros ecocardiográficos em cães tratados com acepromazina e fentanil

Considering that the use of tranquillizers could optimize the performance of the echocardiogram, this study aimed to evaluate the effect of protocols with acepromazine and fentanyl on the echocardiographic parameters of healthy dogs, besides their effect in systolic blood pressure (SBP), respiratory rate (RR), heart rate (HR), time spent for examination and sedation scale. Ten adult dogs were submitted to different tranquilizing protocols 20 minutes before the echocardiographic examination, totalling five treatments for each pair, performed at seven-day intervals between evaluations. The treatments were CT (control treatment), IAT (intramuscular acepromazine), OAT (oral acepromazine), FT (fentanyl) and AFT (acepromazine associated with fentanyl). In addition to the echocardiographic evaluation, SBP, degree of reassurance, duration of the exam, HR and RR in the different protocols were evaluated. There was a significant decrease of SBP in OAT. There was a significant reduction in left ventricular diameter during systole and diastole and mitral annular movement in IAT, OAT and AFT, compared with CT. There was a decrease in tricuspid annular plane systolic excursion and increase in mitral E/mitral A ratio in IAT and OAT when compared with CT. All the tranquillizer protocols studied were found to significantly reduce HR, that facilitated the echocardiographic examination.(AU)

Considerando que o uso de tranquilizantes poderia otimizar a realização do ecocardiograma, objetivou-se com este estudo avaliar o efeito da tranquilização com acepromazina e fentanil sobre os parâmetros ecocardiográficos em cães saudáveis, bem como o efeito na pressão arterial sistólica (PAS), na frequência respiratória (FR), na frequência cardíaca (FC), no tempo gasto para a realização do exame e na escala de sedação. Dez cães adultos foram submetidos a diferentes protocolos tranquilizantes, 20 minutos antes da avaliação ecocardiográfica, totalizando cinco tratamentos para cada dupla, realizados com intervalos de sete dias entre as avaliações. Os tratamentos foram: TC (tratamento controle), TAI (acepromazina intramuscular), TAO (acepromazina oral), TF (fentanil) e TAF (acepromazina associada ao fentanil). Além dos parâmetros ecocardiográficos, foram avaliados a PAS, o grau de tranquilização, o tempo de duração do exame e a FC e a FR nos diferentes protocolos. Houve diminuição significativa da PAS no TAO. Observou-se redução significativa do diâmetro do ventrículo esquerdo em sístole e diástole e do movimento anular de mitral nos protocolos TAI, TAO e TAF, comparados com o TC. Observou-se também uma redução da excursão sistólica do plano anular tricúspide e aumento da relação mitral E/mitral A nos protocolos TAI e TAO quando comparados ao TC. Todos os protocolos de tranquilização reduziram significativamente a FC, o que facilitou a realização do exame.(AU)

Echocardiographic parameters in dogs treated with acepromazine and fentanyl / Parâmetros ecocardiográficos em cães tratados com acepromazina e fentanil

Considering that the use of tranquillizers could optimize the performance of the echocardiogram, this study aimed to evaluate the effect of protocols with acepromazine and fentanyl on the echocardiographic parameters of healthy dogs, besides their effect in systolic blood pressure (SBP), respiratory rate (RR), heart rate (HR), time spent for examination and sedation scale. Ten adult dogs were submitted to different tranquilizing protocols 20 minutes before the echocardiographic examination, totalling five treatments for each pair, performed at seven-day intervals between evaluations. The treatments were CT (control treatment), IAT (intramuscular acepromazine), OAT (oral acepromazine), FT (fentanyl) and AFT (acepromazine associated with fentanyl). In addition to the echocardiographic evaluation, SBP, degree of reassurance, duration of the exam, HR and RR in the different protocols were evaluated. There was a significant decrease of SBP in OAT. There was a significant reduction in left ventricular diameter during systole and diastole and mitral annular movement in IAT, OAT and AFT, compared with CT. There was a decrease in tricuspid annular plane systolic excursion and increase in mitral E/mitral A ratio in IAT and OAT when compared with CT. All the tranquillizer protocols studied were found to significantly reduce HR, that facilitated the echocardiographic examination.(AU)

Considerando que o uso de tranquilizantes poderia otimizar a realização do ecocardiograma, objetivou-se com este estudo avaliar o efeito da tranquilização com acepromazina e fentanil sobre os parâmetros ecocardiográficos em cães saudáveis, bem como o efeito na pressão arterial sistólica (PAS), na frequência respiratória (FR), na frequência cardíaca (FC), no tempo gasto para a realização do exame e na escala de sedação. Dez cães adultos foram submetidos a diferentes protocolos tranquilizantes, 20 minutos antes da avaliação ecocardiográfica, totalizando cinco tratamentos para cada dupla, realizados com intervalos de sete dias entre as avaliações. Os tratamentos foram: TC (tratamento controle), TAI (acepromazina intramuscular), TAO (acepromazina oral), TF (fentanil) e TAF (acepromazina associada ao fentanil). Além dos parâmetros ecocardiográficos, foram avaliados a PAS, o grau de tranquilização, o tempo de duração do exame e a FC e a FR nos diferentes protocolos. Houve diminuição significativa da PAS no TAO. Observou-se redução significativa do diâmetro do ventrículo esquerdo em sístole e diástole e do movimento anular de mitral nos protocolos TAI, TAO e TAF, comparados com o TC. Observou-se também uma redução da excursão sistólica do plano anular tricúspide e aumento da relação mitral E/mitral A nos protocolos TAI e TAO quando comparados ao TC. Todos os protocolos de tranquilização reduziram significativamente a FC, o que facilitou a realização do exame.(AU)

Effects of three acepromazine doses on the incidence of morphine-induced vomiting, sedation and some physiological variables in dogs

Background: Acepromazine was found to reduce the incidence of vomiting induced by opioids such as morphine, hydromorphone and oxymorphone in dogs. Despite the effectiveness of the phenothiazine in preventing opioid-induced vomiting in this species, a single dose of acepromazine (0.05 mg/kg) was tested and the influence of dose on the antiemetic effect of the drug is unknown. The primary objective of this study was to evaluate the effect of three acepromazine doses on the incidence of vomiting induced by morphine in dogs. A secondary aim was to assess the degree of sedation and effects on physiological variables following administration of the combinations tested.Materials, Methods & Results: All dogs received 0.5 mg/kg morphine (IM). Fifteen min before morphine, dogs in the Control, ACPLD, ACPMD and ACPHD groups were administered (IM) physiological saline or acepromazine at doses of 0.025, 0.05 and 0.1 mg/kg, respectively. In Phase 1, purpose-bred dogs (n = 8) underwent each of the four treatments in a randomized, crossover design; the incidence of vomiting, sedation, pulse rate (PR), systolic, mean and diastolic blood pressures (SAP, MAP and DAP) were investigated for 60 min. Sedation was assessed by a numeric descriptive scale (NDS, range 0-3) and a simple numerical scale (SNS, range 1-10). In Phase 2, client-owned dogs (n = 50) received a single treatment and only the incidence of vomiting was assessed. There was no significant difference between groups on the incidence of vomiting recorded in Phase 1, Phase 2 and the average of Phases 1 and 2. A significant decrease in PR was observed in most groups but no significant difference was detected between groups. Blood pressure decreased in all groups; during most of the evaluation period, SAP, MAP and DAP were significantly higher in the Control than in other treatments. Dogs in this study presented mild to intense sedation.[...]